Ibritumomab tiuxetan

Zevalin

Pictures

hydrinatibritumomabtiuxetaninjectioninjectable jpg

IBRITUMOMAB TIUXETAN Injection Injectable

---

heatmap 01 jpg

Life after Treatment Online Resources

---

86130001 jpg

ZEVALIN Therapeutic Regimen Administration

---

p04321b2 jpg

---

zevalin jpg

---

zevalin1 gif

process may adversely impact therapeutic results In 111 ZEVALIN and Y 90 ZEVALIN should not be used in the absence of the Rituximab pre dose See IMAGE ACQUISITION AND INTERPRETATION ZEVALIN Therapeutic Regimen Administration

---

l71120596003 jpeg

Click on image to view larger version FIGURE 3 Anterior whole body images obtained at 4 A 63 B and 140 C h after injection of 185 MBq 5 mCi 1 6 mg 111In ibritumomab tiuxetan Scan shows expected acceptable

---

l80230141004 jpeg

Click on image to view larger version FIGURE 4 Serial whole body anterior gamma camera images after injection of 111In ibritumomab tiuxetan illustrate normal biodistribution including blood pool diminishes over time liver

---

FlinnIan jpg

EDITED COMMENTS ECOG E4402 Phase III randomized study of rituximab in patients with low tumor burden indolent non Hodgkin s lymphoma In the ECOG E4402 trial patients are treated up

---

Picture 1 1 gif

preparative regimen using radioimmunotherapy This Phase I study employs high doses of Zevalin ® yttrium 90 labeled ibritumomab tiuxetan and stem cell transplant 1 1 Nontransplant rituximab cyclophosphamide regimen The schema for our nontransplant regimen was based on the ECOG E2499 trial and previous studies of

---

8 1147 4 jpg

The major toxicity associated with ibritumomab tiuxetan is a severe prolonged and delayed myelosuppression Unlike traditional chemotherapy more than half of patients become neutropenic

---

coverfig gif

About the Cover Images obtained early 4 h left and late 48 h right after administration of ibritumomab tiuxetan show decrease in blood pool over time and uptake in inguinal lymph nodes and brain at 48

---

Fig1 OTFZevalin jpg

Nuclear and correlative imaging in a patient undergoing radio immunotherapy with Yttrium 90 Ibritumomab Tiuxetan Zevalin

---

200301 76 jpg

IDEC Pharmaceuticals Corporation San Diego offers Zevalin ibritumomab tiuxetan a new class of cancer treatments called radioimmunotherapies It is indicated for the

---

reg jpg

3319 Health Related Quality of Life in Patients with Advanced Stage Follicular Lymphoma Receiving Consolidation with 90Y Ibritumomab Tiuxetan Zevalin of First Remission Results from the Randomized Phase 3 First Line Indolent Trial FIT Session Type Poster Session Board 538 III Kathleen Gondek Sonalee Shah Angelika Bischof

---

36FD5AE9 A170 0714 C33501DB7CDE6555 jpg

remain free of disease for long periods of time more than 50 will develop recurrence and then receive other types of chemotherapy or treatments for their relapse External beam radiation is delivered outside of the body to an area inside a patient where a cancer is believed to exist This traditional form of radiation therapy has not proven to prevent

---

supplyprep gif

---

description gif

---

image php

---

bannerimage php

---